-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Oric Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
- Oric Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $261K, a 3.16% increase year-over-year.
- Oric Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.03M, a 6.83% increase from 2022.
- Oric Pharmaceuticals, Inc. annual Depreciation for 2022 was $966K, a 7.69% increase from 2021.
- Oric Pharmaceuticals, Inc. annual Depreciation for 2021 was $897K, a 7.53% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)